Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning

被引:39
作者
Noureddin, Mazen [1 ]
Ntanios, Fady [2 ]
Malhotra, Deepa [2 ]
Hoover, Katherine [2 ]
Emir, Birol [2 ]
McLeod, Euan [3 ]
Alkhouri, Naim [4 ]
机构
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Karsh Div Gastroenterol & Hepatol, 8900 Beverly Blvd Suite 250, Los Angeles, CA 90048 USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Ltd, Tadworth, England
[4] Arizona Liver Hlth, Chandler, AZ USA
关键词
NONALCOHOLIC FATTY LIVER; DISEASE; STEATOHEPATITIS; EPIDEMIOLOGY; FIBROSIS; ASSOCIATION; MORTALITY; RISK;
D O I
10.1002/hep4.1935
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This cohort analysis investigated the prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD with fibrosis at different stages, associated clinical characteristics, and comorbidities in the general United States population and a subpopulation with type 2 diabetes mellitus (T2DM), using the National Health and Nutrition Examination Survey (NHANES) database (2017-2018). Machine learning was explored to predict NAFLD identified by transient elastography (FibroScan(R)). Adults >= 20 years of age with valid transient elastography measurements were included; those with high alcohol consumption, viral hepatitis, or human immunodeficiency virus were excluded. Controlled attenuation parameter >= 302 dB/m using Youden's index defined NAFLD; vibration-controlled transient elastography liver stiffness cutoffs were <= 8.2, <= 9.7, <= 13.6, and >13.6 kPa for F0-F1, F2, F3, and F4, respectively. Predictive modeling, using six different machine-learning approaches with demographic and clinical data from NHANES, was applied. Age-adjusted prevalence of NAFLD and of NAFLD with F0-F1 and F2-F4 fibrosis was 25.3%, 18.9%, and 4.4%, respectively, in the overall population and 54.6%, 32.6%, and 18.3% in those with T2DM. The highest prevalence was among Mexican American participants. Test performance for all six machine-learning models was similar (area under the receiver operating characteristic curve, 0.79-0.84). Machine learning using logistic regression identified male sex, hemoglobin A1c, age, and body mass index among significant predictors of NAFLD (P <= 0.01). Conclusion: Data show a high prevalence of NAFLD with significant fibrosis (>= F2) in the general United States population, with greater prevalence in participants with T2DM. Using readily available, standard demographic and clinical data, machine-learning models could identify subjects with NAFLD across large data sets.
引用
收藏
页码:1537 / 1548
页数:12
相关论文
共 35 条
  • [11] EASL, 2016, OBESITY FACTS, V9, P65, DOI [10.1007/s00125-016-3902-y, 10.1159/000443344, 10.1016/j.jhep.2015.11.004]
  • [12] Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    Eddowes, Peter J.
    Sasso, Magali
    Allison, Michael
    Tsochatzis, Emmanouil
    Anstee, Quentin M.
    Sheridan, David
    Guha, Indra N.
    Cobbold, Jeremy F.
    Deeks, Jonathan J.
    Paradis, Valerie
    Bedossa, Pierre
    Newsome, Philip N.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : 1717 - 1730
  • [13] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Estes, Chris
    Razavi, Homie
    Loomba, Rohit
    Younossi, Zobair
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 123 - 133
  • [14] NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
    Godoy-Matos, Amelio F.
    Silva Junior, Wellington S.
    Valerio, Cynthia M.
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [15] Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort
    Harrison, Stephen A.
    Gawrieh, Samer
    Roberts, Katharine
    Lisanti, Christopher J.
    Schwope, Ryan B.
    Cebe, Katherine M.
    Paradis, Valerie
    Bedossa, Pierre
    Whitehead, Jennifer M. Aldridge
    Labourdette, Aymeric
    Miette, Veronique
    Neubauer, Stefan
    Fournier, Celine
    Paredes, Angelo H.
    Alkhouri, Naim
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 (02) : 284 - 291
  • [16] Using AUC and accuracy in evaluating learning algorithms
    Huang, J
    Ling, CX
    [J]. IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING, 2005, 17 (03) : 299 - 310
  • [17] Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018
    Kim, Donghee
    Cholankeril, George
    Loomba, Rohit
    Ahmed, Aijaz
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (01) : 261 - 263
  • [18] Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018
    Kim, Donghee
    Cholankeril, George
    Loomba, Rohit
    Ahmed, Aijaz
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1499 - +
  • [19] Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
    Kim, Donghee
    Kim, W. Ray
    Kim, Hwa Jung
    Therneau, Terry M.
    [J]. HEPATOLOGY, 2013, 57 (04) : 1357 - 1365
  • [20] Burden of Disease due to Nonalcoholic Fatty Liver Disease
    Muthiah, Mark D.
    Sanyal, Arun J.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (01) : 1 - +